Pascal Campard-Kienlen

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Tau pathological activity in plasma before the onset of symptomatic Alzheimer's disease.

Tau pathological activity in plasma before the onset of symptomatic Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease.

Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 06, 2025

Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model.

Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model.

Journal: Acta neuropathologica communications

Published: June 30, 2025

KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer's disease.

KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: May 23, 2025

KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer's disease.

KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: May 23, 2025

The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

Journal: Acta neuropathologica

Published: March 05, 2025

Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals.

Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals.

Journal: Alzheimer's research & therapy

Published: April 15, 2024

Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia.

Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia.

Journal: International journal of molecular sciences

Published: December 15, 2023

Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology.

Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology.

Journal: Acta neuropathologica communications

Published: May 05, 2023

Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.

Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.

Journal: Nature communications

Published: December 05, 2022

Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates.

Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates.

Journal: Biomedicines

Published: September 07, 2022

Deconstruction of Neurotrypsin Reveals a Multi-factorially Regulated Activity Affecting Myotube Formation and Neuronal Excitability.

Deconstruction of Neurotrypsin Reveals a Multi-factorially Regulated Activity Affecting Myotube Formation and Neuronal Excitability.

Journal: Molecular neurobiology

Published: June 03, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026